Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COLOPEC trial of adjuvant HIPEC after curative colon cancer resection
2014-002794-11Phase 3Active
- Sponsor
- Academic Medical Center
- Start
- Sep 2014
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of oxaliplatin, folinic acid and fluorouracil in colon cancer (2 arms), sponsored by Academic Medical Center. Primary endpoint: Peritoneal recurrence-free survival. Started Sep 2014; status: active.
02
Drugs
oxaliplatinfolinic acidfluorouracil
03
Conditions
colon cancer
Beyond the preview
Go deeper on 2014-002794-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002794-11.